title: All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.
authors.affiliation: Service Clinique des Maladies du Sang, Hôpital St Louis, Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Degos
authors.forename: H
authors.initials: H
authors.lastname: Dombret
authors.forename: C
authors.initials: C
authors.lastname: Chomienne
authors.forename: M T
authors.initials: MT
authors.lastname: Daniel
authors.forename: J M
authors.initials: JM
authors.lastname: Micléa
authors.forename: C
authors.initials: C
authors.lastname: Chastang
authors.forename: S
authors.initials: S
authors.lastname: Castaigne
authors.forename: P
authors.initials: P
authors.lastname: Fenaux
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation / Q000187:drug effects; D004351:Drug Resistance; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D018365:Neoplasm, Residual / Q000175:diagnosis; D016019:Survival Analysis; D013927:Thrombosis / Q000139:chemically induced; D014212:Tretinoin / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014212:Tretinoin